#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neuroendocrine tumour of the lung Chronic lymphocytic leukaemia Dementia with Lewy bodies Langerhans cell sarcoma Duchenne muscular dystrophy gene carrier Prolymphocytic leukaemia Obesity Oesophageal achalasia Loeys-Dietz syndrome Lymphangiosarcoma Bladder cancer Peripheral primitive neuroectodermal tumour of soft tissue Epilepsy Essential thrombocythaemia Human papilloma virus immunisation More trials…

    Learn about Rare Diseases

    Hyperoxaluria – Basic Information Idiopathic pulmonary fibrosis – Life with Disease Anaplastic thyroid cancer – Treatment Haemophilia A without inhibitors – Life with Disease Medulloblastoma recurrent – Basic Information Cholangitis sclerosing – Diagnostics Testicular leiomyosarcoma – Trials in Disease Acute respiratory distress syndrome Basal cell naevus syndrome – Trials in Disease Hereditary optic atrophy – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Odevixibat Soft Paraffin And Fat Products Specific Nucleic Acid Sna-Papi Isis 678354 Sodium Salt Mirodenafil Dihydrochloride Nmd670 Venglustat 204-NETU TEDUGLUTIDE Alternaria Alternata (402) Caraway Oil Wt1/Il15/Il15Ra Mrna Dc Mesna Tilsotolimod Sodium Suvecaltamide Lenacapavir Sodium Somapacitan Revumenib Gefitinib Ly3537982 More therapies…

    Learn about Your Condition

    Monogenic diabetes Pathogen resistance Somatic symptom disorder Small intestine carcinoma Skin wrinkling SAPHO syndrome Inner ear disorder Thyroid disorder Osteoporosis Pancreaticoduodenectomy Spinal pain Amyotrophic lateral sclerosis Hodgkin's disease refractory Pyelonephritis acute Diarrhoea More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Evangelismos S.A.

Evangelismos S.A.

Ipsiladou 45-47, Athens, 106 76, Greece

Want to learn more about this study or check if you can participate? Contact us.

  • Study of fosmanogepix compared to standard antifungal drugs for treating invasive mold infections in adults

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Anidulafungin
    • Caspofungin Acetate
    • FOSMANOGEPIX
    Austria Belgium France Germany Greece Italy +2

  • Effectiveness of Macrogol 3350 With Electrolytes and Sodium Picosulfate/Magnesium Citrate Combination for Bowel Preparation in Patients With Inadequate Previous Colonoscopy Preparation

    Recruiting

    3 1 1
    Investigated Drugs:
    • Macrogol 3350
    • Potassium Chloride
    • Sodium Chloride
    Greece

  • Study of Seladelpar Treatment in Patients with Primary Biliary Cholangitis and Compensated Cirrhosis

    Recruiting

    3 1
    Investigated Drugs:
    • Seladelpar
    Austria Belgium Czechia Denmark France Germany +7

  • Study to Find Treatments for Chronic Kidney Disease Using Finerenone in Patients with Standard Care

    Recruiting

    3 1 1
    Investigated Drugs:
    • Finerenone
    Greece Spain

  • Study on the Effectiveness of Lisaftoclax and Azacitidine in Adults with Newly Diagnosed Higher Risk Myelodysplastic Syndrome

    Recruiting

    3 1 1
    Investigated Diseases:
    • Myelodysplastic syndrome
    Investigated Drugs:
    • Azacitidine
    • Lisaftoclax
    Belgium Bulgaria Czechia Finland France Germany +7

  • Study of Zilovertamab Vedotin and Drug Combination for Untreated Diffuse Large B-Cell Lymphoma Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma
    Investigated Drugs:
    • Zilovertamab Vedotin
    • Betamethasone Sodium Phosphate
    • Cyclophosphamide
    Belgium Denmark France Greece Hungary Italy +5

  • Study on Eltrekibart and Mirikizumab for Adults with Moderate to Severe Ulcerative Colitis

    Recruiting

    2 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Humanised Igg4 Kappa Monoclonal Antibody Against Cxcl1, Cxcl2, Cxcl3, Cxcl5, Cxcl6, Cxcl7 And Cxcl8
    • Mirikizumab
    Belgium Croatia Czechia Denmark France Germany +8

  • Study on the Effectiveness and Safety of Fosmanogepix Compared to Caspofungin and Fluconazole for Adults with Candidemia or Invasive Candidiasis

    Recruiting

    3 1 1
    Investigated Drugs:
    • Caspofungin
    • Fluconazole
    • FOSMANOGEPIX
    Austria Belgium Bulgaria France Germany Greece +2

  • Study of DDCART-CD19 cells with cyclophosphamide and fludarabine for children and young adults (up to 39 years) with recurrent acute leukemia after stem cell transplant

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia recurrent
    Investigated Drugs:
    • Ddcart‐Cd19
    • Cyclophosphamide
    • Fludarabine Phosphate
    Greece

  • Study of Selinexor, Dexamethasone, and Bortezomib for Patients with Refractory Multiple Myeloma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    • Plasma cell myeloma refractory
    Investigated Drugs:
    • Olanzapine
    • Ondansetron
    • Selinexor
    Greece
Previous Page
1 2 3 4 5 6 … 14
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!